A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00121836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study of Xeloda Plus Avastin at Time of Disease Progression in Treatment-naïve Women With HER2-negative Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This single-arm study was designed to evaluate the efficacy and safety of oral Xeloda plus intravenous Avastin as first-line treatment in women with metastatic breast cancer. Patients received Xeloda 1000 mg/m² orally (PO) twice daily (BID) on Days 1-15, and Avastin 15 mg intravenously (IV) on Day 1 of each 3-week cycle. The anticipated time on study treatment was until disease progression or unacceptable toxicity. The target sample size was \<100 individuals.
Study identification
- NCT ID
- NCT00121836
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 109 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Apr 27, 2011
2005 – 2008
United States locations
- U.S. sites
- 57
- U.S. states
- 22
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35022 | — |
| Not listed | Birmingham | Alabama | 35205 | — |
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Birmingham | Alabama | 35211 | — |
| Not listed | Birmingham | Alabama | 35213 | — |
| Not listed | Birmingham | Alabama | 35235 | — |
| Not listed | Burbank | California | 91505 | — |
| Not listed | Glendale | California | 91204 | — |
| Not listed | Glendale | California | 91206 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | San Diego | California | 92121 | — |
| Not listed | Farmington | Connecticut | 06030 | — |
| Not listed | Bonita Springs | Florida | 34135 | — |
| Not listed | Boynton Beach | Florida | 33435 | — |
| Not listed | Bradenton | Florida | 34209 | — |
| Not listed | Cape Coral | Florida | 33990 | — |
| Not listed | Fort Myers | Florida | 33901 | — |
| Not listed | Fort Myers | Florida | 33908 | — |
| Not listed | Naples | Florida | 34102 | — |
| Not listed | Naples | Florida | 34119 | — |
| Not listed | Port Charlotte | Florida | 33980 | — |
| Not listed | Sarasota | Florida | 34232 | — |
| Not listed | Sarasota | Florida | 34236 | — |
| Not listed | Venice | Florida | 34292 | — |
| Not listed | Atlanta | Georgia | 30341 | — |
| Not listed | Augusta | Georgia | 30901 | — |
| Not listed | Tucker | Georgia | 30084 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Indianapolis | Indiana | 46219 | — |
| Not listed | Waterloo | Iowa | 50702 | — |
| Not listed | Scarborough | Maine | 04074 | — |
| Not listed | Prince Frederick | Maryland | 20678 | — |
| Not listed | Lansing | Michigan | 48909 | — |
| Not listed | Kansas City | Missouri | 64064 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | Kansas City | Missouri | 64154 | — |
| Not listed | Kansas City | Missouri | 66112 | — |
| Not listed | Kansas City | Missouri | 66210 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Omaha | Nebraska | 68114 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Brick | New Jersey | 08724 | — |
| Not listed | Neptune City | New Jersey | 07754 | — |
| Not listed | Red Bank | New Jersey | 07701 | — |
| Not listed | Rochester | New York | 14642 | — |
| Not listed | Hickory | North Carolina | 28602 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Beaufort | South Carolina | 29902 | — |
| Not listed | Charleston | South Carolina | 29406 | — |
| Not listed | Florence | South Carolina | 29506 | — |
| Not listed | Hilton Head Island | South Carolina | 29926 | — |
| Not listed | Sumter | South Carolina | 29150 | — |
| Not listed | Abingdon | Virginia | 24211 | — |
| Not listed | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00121836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2011 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00121836 live on ClinicalTrials.gov.